⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
NCCN Foundation Announces Annual Awards to Support Future Leaders for Cancer Innovation
prnewswire.com
EXEL
MRK
PFE
2026 Ascend A-List Awards: Honoring Business Leaders Shaping the Future
prnewswire.com
PFE
DIS
BMY
RHI
TD
MCO
TGT
JPM
DOW
BAC
ED
PRU
Brooklyn Is Building the Future -- And It Starts This Spring
prnewswire.com
MSFT
JPM
PFE
Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth
globenewswire.com
NVCR
MRK
PFE
ABBV
Medulloblastoma Drugs Market Analysis and Growth Forecast 2026-2030 & 2035 by Drug Candidate, Product, Route of Administration, Distribution Channel, End-user and Region
globenewswire.com
PFE
NVS
BMY
MRK
AZN
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate
globenewswire.com
UTHR
PFE
AMGN
JNJ
ABBV
MRK
BMY
MAC
Glioblastoma Multiforme (GBM) Treatment Market to Grow by $1.44 Billion During 2026-2030: Strategic Analysis of 23 Industry Players
globenewswire.com
NVCR
MRK
PFE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect
accessnewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
From Commercialization to Global Leadership: Innogen (2591.HK) Unlocks the Strategic Value of Its Ultra-Long-Acting GLP-1 Receptor Agonist
prnewswire.com
PFE